Skip to content Skip to navigation

Comparison of structural progression between ciliopathy and non-ciliopathy associated with autosomal recessive retinitis pigmentosa.

TitleComparison of structural progression between ciliopathy and non-ciliopathy associated with autosomal recessive retinitis pigmentosa.
Publication TypeJournal Article
Year of Publication2019
AuthorsTakahashi, Vitor K. L., Xu Christine L., Takiuti Julia T., Apatoff Mary Ben L., Duong Jimmy K., Mahajan Vinit B., and Tsang Stephen H.
JournalOrphanet J Rare Dis
Volume14
Issue1
Pagination187
Date Published2019 08 01
ISSN1750-1172
Abstract

BACKGROUND: To evaluate and compare the progression of ciliopathy and non-ciliopathy autosomal recessive Retinitis Pigmentosa patients (arRP) by measuring the constriction of hyperautofluorescent rings in fundus autofluorescence (FAF) images and the progressive shortening of the ellipsoid zone line width obtained by spectral-domain optical coherence tomography (SD-OCT).

RESULTS: For the ciliopathy group, the estimated mean shortening of the ellipsoid zone line was 259 μm per year and the ring area decreased at a rate of 2.46 mm per year. For the non-ciliopathy group, the estimated mean shortening of the ellipsoid zone line was 84 μm per year and the ring area decreased at a rate of 0.7 mm per year.

CONCLUSIONS: Our study was able to quantify and compare the loss of EZ line width and short-wavelength autofluorescence (SW-AF) ring constriction progression over time for ciliopathy and non-ciliopathy arRP genes. These results may serve as a basis for modeling RP disease progression, and furthermore, they could potentially be used as endpoints in clinical trials seeking to promote cone and rod survival in RP patients.

DOI10.1186/s13023-019-1163-9
Alternate JournalOrphanet J Rare Dis
PubMed ID31370859
PubMed Central IDPMC6676605
Grant ListP30EY019007 / NH / NIH HHS / United States
R01EY024698 / NH / NIH HHS / United States
R01EY026682 / NH / NIH HHS / United States
R01EY018213 / NH / NIH HHS / United States
R21AG050437 / NH / NIH HHS / United States
5P30CA013696 / / National Cancer Institute Core / International